1. Home
  2. CETX vs CVKD Comparison

CETX vs CVKD Comparison

Compare CETX & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cemtrex Inc.

CETX

Cemtrex Inc.

HOLD

Current Price

$1.79

Market Cap

17.5M

Sector

Technology

ML Signal

HOLD

Logo Cadrenal Therapeutics Inc.

CVKD

Cadrenal Therapeutics Inc.

HOLD

Current Price

$7.72

Market Cap

17.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CETX
CVKD
Founded
1998
2022
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.5M
17.0M
IPO Year
1998
2023

Fundamental Metrics

Financial Performance
Metric
CETX
CVKD
Price
$1.79
$7.72
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$32.00
AVG Volume (30 Days)
8.6M
53.5K
Earning Date
02-13-2026
03-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$76,488,088.00
N/A
Revenue This Year
$20.41
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.39
N/A
52 Week Low
$1.74
$6.42
52 Week High
$42.60
$22.90

Technical Indicators

Market Signals
Indicator
CETX
CVKD
Relative Strength Index (RSI) 38.71 46.70
Support Level $1.74 $7.07
Resistance Level $1.95 $8.21
Average True Range (ATR) 0.28 0.57
MACD -0.04 0.09
Stochastic Oscillator 1.91 45.11

Price Performance

Historical Comparison
CETX
CVKD

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded into a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security systems. The company's operating segment includes the Security segment and the Industrial Services segment. The security segment provides end-to-end security to all industrial, corporate, and governmental security via its owned subsidiary, Vicon. Whereas the AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in-plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment, and from the USA. It also operates UK, USA, and Other.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: